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The surge of the new interdisciplinary centers, the new
titles and slogans, these days, are all a genuine attempt to
lead a responsible change of the research and development
as well as the treatment paradigm towards better healthcare
in particular, and well being to ALL, in general. The goal is
to change the paradigm in health care - from delayed inter-
ventional medicine to predictive personally tailored medi-
cine, from reactive to preventive medicine and from disease
to wellness, facing the major needs of society. Based on the
remarkable achievements in the past decade, the CKTS
(Converging Knowledge, Technology and Society)
approach was presented by the NSF (Dec. 2012) reflecting
the series of workshops held around the world. The “Holis-
tic approaches to wellness and human development”, is one
focus, among other wide range of recommendations in the
broad area of science. That is fully aligned with the practice
of medicine that is moving from a passive coincidence
model to an active convergence model, including micro
and macro environmental effects. At the center of this
transformation is the intersection of physiology, molecular
profiling and information technology, combined with a
number of converging technologies that affected the
human cognition, communication and quality of life. The
common denominators were the availability and compat-
ibility of technologies, functional imaging including brain
imaging, enabling of big data analysis, etc. The practical
goal is to provide inspired translational research from basic
science to preventive, predictive and personalized medicine.
As a practical enabling system, a Simultaneous Systematic
Analysis (SSA) approach is suggested, to provide the broad-
est possible insight into the individual comprehensive func-
tioning in the surroundings - as one refined complex
system- over time and modes of actions. The targeted plat-
form envisioned will enable and encourage an open, inno-
vative systematic effort, sharing all findings and combining
all acquired knowledge, technologies and expertise, focused
on a specific phenomenon or disease. The approach sug-
gests an operational mode for multilevel, multisource
research that would reduce barriers, encourage creativity
and innovative research, while enabling responsible and
safe sharing of all findings. It can be envisioned as a matrix
scheme, applied, for example, to drug efficacy, in which the
rows represent the various levels of the patient (healthy,
diagnosed but not treated, treated, etc) and the columns
represents the various research and professionals working
groups, each focusing on a specific aspect of the micro- and
macro-environment (see figure 1). The goal is to involve all
stakeholders (industry, governmental- policy, regulatory,
patients, etc) and the professionals at all R&D levels, in an
ongoing structural and coherent discussions. The CHEST
(Converging Humanities, Education, Science and Technol-
ogy) methodology would be utilized to provide the platform
for open discussion, while bridging the gaps and reducing
any formal or conceptual barriers between all partners. The
idea is to bring on board the ethics professionals, for exam-
ple, even at the basic science level, discuss all mental and
physical aspects, embed the “caution” and “cognition”
points of view etc - all which will ensure innovative think-
ing as well as reliable, balanced and profitable solutions to
All. These creative operational schemes yielding the essen-
tial mutual fertility, could shorten the lead time to mechan-
ism understanding and thus are essential in enabling
personalized and preventive medicine, providing best fitting
treatments and products. Applying this approach to drug
and treatment applications, as presented in the matrix, may
have a broad economical and sociological impact yielding
demographic changes and thus political issues.
The iii-3 Cancer Center - (Infection-Immunity-Inflam-
mation Driven Cancer Diseases), at Tel Aviv University, is
another feasibility study, as an example, to the SSA
approach (see figure 2). The goal is to combine the study of
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all levels with the macro features such as environmental
studies, ethics, psychology, community etc, in order to pro-
vide inspired translational research from basic science to
personalized medicine at the cancer Infection- Immunity-
Inflammation focused group. The Infection - Immunity -
Inflammation triangle is at the heart of this approach, as a
core factor in cancer development and treatment, including
the interplay with the surrounding factors. Through chan-
ging the paradigm and combining all relevant research
areas and know-how in the lab and clinic, iii-Cancer will
enable to advance towards innovative reliable preventive,
predictive and personalized cancer treatment.
In order to apply the SSA approach, as true for other
initiatives, further formal and managerial steps have to be
taken by regulatory and policy makers agencies, as a pre-
requisite for applying such joint open flows working
schemes:
- ensuring intellectual property, simplifying and short-
ening the processes.
- shortening the peer review process (as was men-
tioned by Leshner in AAAS 2011)
- shortening the time-lag for patent administration -
the regulatory scheme and procedures.
- education paradigm change at all formal levels from
childhood to graduate studies.
- academic institute’s structure and culture adaption at
all levels: teaching and collaborative research paradigm
including adjusting the personal evaluation and promo-
tion schemes.
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Figure 1 The Matrix Approach applied to a specific disease. Simultaneous Systematic Analysis and joint efforts among all research groups and
professionals.
Figure 2 The Center for Interdisciplinary Research on Infection-
Immunity-Inflammation Driven Cancer Diseases
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